Clearstead Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $556K | Sell |
23,084
-4,435
| -16% | -$116K | 0.07% | 106 |
|
|
2026
Q1 | $773K | Sell |
27,519
-1,526
| -5% | -$40.6K | 0.13% | 85 |
|
|
2025
Q4 | $723K | Sell |
29,045
-1,941
| -6% | -$48.9K | 0.11% | 97 |
|
|
2025
Q3 | $790K | Sell |
30,986
-2,856
| -8% | -$70.5K | 0.13% | 86 |
|
|
2025
Q2 | $820K | Buy |
33,842
+6,525
| +24% | +$152K | 0.16% | 81 |
|
|
2025
Q1 | $692K | Sell |
27,317
-150
| -0.5% | -$3.92K | 0.15% | 82 |
|
|
2024
Q4 | $729K | Sell |
27,467
-16
| -0.1% | -$434 | 0.16% | 76 |
|
|
2024
Q3 | $795K | Sell |
27,483
-621
| -2% | -$18.1K | 0.19% | 69 |
|
|
2024
Q2 | $786K | Sell |
28,104
-420
| -1% | -$11.6K | 0.2% | 64 |
|
|
2024
Q1 | $792K | Sell |
28,524
-4,192
| -13% | -$116K | 0.21% | 67 |
|
|
2023
Q4 | $942K | Sell |
32,716
-2,975
| -8% | -$89.9K | 0.26% | 59 |
|
|
2023
Q3 | $1.18M | Buy |
35,691
+1,188
| +3% | +$42K | 0.39% | 48 |
|
|
2023
Q2 | $1.32M | Sell |
34,503
-10,810
| -24% | -$421K | 0.42% | 44 |
|
|
2023
Q1 | $1.85M | Buy |
45,313
+524
| +1% | +$22.6K | 0.59% | 33 |
|
|
2022
Q4 | $2.29M | Sell |
44,789
-2,747
| -6% | -$132K | 0.77% | 27 |
|
|
2022
Q3 | $2.08M | Buy |
47,536
+26,269
| +124% | +$1.28M | 0.72% | 27 |
|
|
2022
Q2 | $1.11M | Hold |
21,267
| – | – | 0.85% | 28 |
|
|
2022
Q1 | $1.1M | Sell |
21,267
-281
| -1% | -$14.6K | 0.71% | 29 |
|
|
2021
Q4 | $1.27M | Hold |
21,548
| – | – | 0.75% | 32 |
|
|
2021
Q3 | $927K | Buy |
21,548
+10,993
| +104% | +$487K | 0.59% | 39 |
|
|
2021
Q2 | $757K | Sell |
10,555
-8,761
| -45% | -$341K | 0.49% | 47 |
|
|
2021
Q1 | $700K | Hold |
19,316
| – | – | 0.52% | 45 |
|
|
2020
Q4 | $711K | Sell |
19,316
-516
| -3% | -$18.9K | 0.42% | 60 |
|
|
2020
Q3 | $691K | Hold |
19,832
| – | – | 0.55% | 43 |
|
|
2020
Q2 | $615K | Sell |
19,832
-896
| -4% | -$30.4K | 0.52% | 47 |
|
|
2020
Q1 | $642K | Sell |
20,728
-93
| -0.4% | -$3.17K | 0.58% | 41 |
|
|
2019
Q4 | $774K | Sell |
20,821
-1,050
| -5% | -$37.4K | 0.57% | 44 |
|
|
2019
Q3 | $746K | Hold |
21,871
| – | – | 0.58% | 45 |
|
|
2019
Q2 | $899K | Sell |
21,871
-276
| -1% | -$11K | 0.72% | 40 |
|
|
2019
Q1 | $893K | Sell |
22,147
-3,758
| -15% | -$151K | 0.75% | 40 |
|
|
2018
Q4 | $1.07M | Sell |
25,905
-2,437
| -9% | -$101K | 1% | 28 |
|
|
2018
Q3 | $1.19M | Sell |
28,342
-2,125
| -7% | -$81.8K | 0.91% | 31 |
|
|
2018
Q2 | $1.05M | Buy |
30,467
+2,796
| +10% | +$95.5K | 0.94% | 28 |
|
|
2018
Q1 | $932K | Buy |
27,671
+1,745
| +7% | +$60K | 0.8% | 43 |
|
|
2017
Q4 | $891K | Hold |
25,926
| – | – | 0.61% | 52 |
|
|
2017
Q3 | $878K | Sell |
25,926
-2,954
| -10% | -$94.9K | 0.65% | 54 |
|
|
2017
Q2 | $748K | Buy |
28,880
+4,775
| +20% | +$151K | 0.59% | 49 |
|
|
2017
Q1 | $782K | Buy |
24,105
+316
| +1% | +$9.96K | 0.65% | 49 |
|
|
2016
Q4 | $733K | Buy |
+23,789
| New | +$726K | 0.66% | 45 |
|
Other funds holding PFE
Clearstead Trust's PFE Position: Q2 2026 in Review
Clearstead Trust reduced its Pfizer (PFE) stake by 16% in Q2 2026, selling an estimated $116K and leaving 23,084 shares worth $556K. The position accounts for 0.07% of the portfolio, ranked #106.
Clearstead Trust first reported a position in PFE in Q4 2016 and has held it in 39 quarters since. The position peaked at $2.29M in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Clearstead Trust held 23,084 shares of Pfizer worth $556K as of Q2 2026.
- Clearstead Trust sold 4,435 Pfizer shares in Q2 2026, an estimated $116K.
- Pfizer made up 0.07% of Clearstead Trust's portfolio in Q2 2026, its #106 holding.
- Clearstead Trust first reported a position in Pfizer in Q4 2016 and has held it in 39 quarters since.
- Clearstead Trust's Pfizer position peaked at $2.29M in Q4 2022.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.